Dec 19, 2017 - While performance for December continues to disappoint, we continue to position the ROTY model account for a profitable 2018.Argenx received a very large price hike from an analyst.Global Blood Therap
Dec 14, 2017 - Arris (NASDAQ:ARRS) fell 6.3% today and touched its lowest point since early September after holding a call where it said it expects margin pressures from memory pricing to stretch some distance into
Dec 11, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Dec 02, 2017 - Shares have risen a decent bit since my initial entries, but I believe 2018 holds substantially more upside ahead.Below I provide a recap of the bullish thesis and recent events.After its September se
Nov 21, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Nov 07, 2017 - Steven Cohen Takes Stake in Karyopharm Therapeutics, Stocks: KPTI,ADMS,ONCS,GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Nov 07, 2017
Oct 04, 2017 - Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood, Stocks: GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Oct 04, 2017
Oct 03, 2017 - Ono is reaping the benefits of Opdivo's growth, but there is ample competition in the PD-1 space, and growth will be tied to clinical success, competitors' results, and government pricing.Ono's intern
Sep 24, 2017 - Four new breakout stocks for Week 39 with better than 10% short-term upside potential. Continuing a 13 week streak of at least one stock gaining greater than 10% in the first 5 days of trading. (26 o
Sep 21, 2017 - Book partial profits on STMicroelectronics.Intercept Pharmaceuticals is a speculative biotech with positive news.Array BioPharma has the money to expand its portfolio.